{"id":230,"date":"2019-11-12T17:22:48","date_gmt":"2019-11-12T22:22:48","guid":{"rendered":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/5-6-antihistamines\/"},"modified":"2023-08-15T12:56:35","modified_gmt":"2023-08-15T16:56:35","slug":"5-6-antihistamines","status":"publish","type":"chapter","link":"https:\/\/opentextbc.ca\/nursingpharmacology\/chapter\/5-6-antihistamines\/","title":{"raw":"5.6 Antihistamines","rendered":"5.6 Antihistamines"},"content":{"raw":"<h1>Antihistamines<\/h1>\r\nDiphenhydramine and Cetirizine are two commonly-seen antihistamine drugs. In this chapter we explore Diphenhydramine.\r\n\r\nDiphenhydramine is an example of a first-generation antihistamine. (See Figures 5.6a[footnote]\"<a href=\"https:\/\/www.flickr.com\/photos\/zenbenjamin\/4948476952\" rel=\"noopener noreferrer\">Benadryl Allergy USA<\/a>\" by <a href=\"https:\/\/www.flickr.com\/photos\/zenbenjamin\/\" rel=\"noopener noreferrer\">ZenBenjamin<\/a> is licensed under <a class=\"internal\" href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/2.0\/\" rel=\"noopener noreferrer\">CC BY-NC-SA 2.0<\/a>[\/footnote] and 5.6b.[footnote]\"<a href=\"https:\/\/commons.wikimedia.org\/wiki\/File:Diphenhydramine_(1).JPG\" rel=\"noopener noreferrer\">diphenhydramine (1)<\/a>\" by <a href=\"https:\/\/commons.wikimedia.org\/wiki\/User:Intropin\" rel=\"noopener noreferrer\">Intropin<\/a> is licensed under<a class=\"internal\" href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/2.0\/\" rel=\"noopener noreferrer\"> CC BY-NC 2.0[\/footnote]<\/a>)\u00a0 Second-generation antihistamines were developed to have fewer side effects. An example of a second-generation antihistamine is cetirizine.\r\n\r\n[caption id=\"attachment_227\" align=\"aligncenter\" width=\"339\"]<img class=\"wp-image-227\" title=\"&quot;Benadryl Allergy USA&quot; by ZenBenjamin is licensed under CC BY-NC-SA 2.0\" src=\"https:\/\/opentextbc.ca\/accessibilitytoolkit\/wp-content\/uploads\/sites\/397\/2019\/11\/image11-5.png\" alt=\"An opened package of Benadryl.\" width=\"339\" height=\"254\" \/> Figure 5.6a Diphenhydramine is a first-generation antihistamine that is available orally or as an IV medication[\/caption]\r\n\r\n[caption id=\"attachment_228\" align=\"aligncenter\" width=\"259\"]<img class=\"wp-image-228\" title=\"&quot;diphenhydramine (1)&quot; by M is licensed under CC BY-NC 2.0\" src=\"https:\/\/opentextbc.ca\/accessibilitytoolkit\/wp-content\/uploads\/sites\/397\/2022\/05\/image10-4-225x300.png\" alt=\"A bottle of diphenhydramine HCI.\" width=\"259\" height=\"345\" \/> Figure 5.6b Diphenhydramine HCl preparation, single dose vial for IV administration[\/caption]\r\n<h2>Mechanism of Action<\/h2>\r\nAntihistamines have the following mechanisms of action: blocks histamine at H1 receptors; inhibits smooth muscle constriction in blood vessels and the respiratory and GI tracts; and decreases capillary permeability, salivation, and tear formation.\r\n<h2>Indications for Use<\/h2>\r\nAntihistamines are used for relief of allergy or cold symptoms.\r\n<h2>Nursing Considerations Across the Lifespan<\/h2>\r\nThis medication is not safe for children under the age of 2 years without a healthcare provider's order.\r\n<h2>Adverse\/Side Effects<\/h2>\r\nFirst-generation medications can cause anticholinergic effects (such as dry mouth, urinary retention, constipation and blurred vision). CNS depression or CNS stimulation with excessive doses can occur, especially in children. Therefore, first-generation antihistamines should be used with caution in the elderly.\r\n\r\nSecond-generation medications may cause headache, nausea, vomiting, dysmenorrhea, and fatigue.[footnote]Frandsen, G. &amp; Pennington, S. (2018). <em>Abrams\u2019 clinical drug: Rationales for nursing practice <\/em>(11th ed.). Wolters Kluwer.[\/footnote]\r\n<h2>Client Teaching &amp; Education<\/h2>\r\nClients should be advised that antihistamines may cause drowsiness, and concurrent use of alcohol or other CNS depressants should be avoided.\u00a0 Clients should take only the recommended amount of medication and not exceed dosing recommendations.\u00a0 Some clients may experience side effects such as dry mouth, and frequent oral hygiene may assist in alleviating discomfort.[footnote]uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a>[\/footnote]\r\n<h1>Diphenhydramine Medication Card<\/h1>\r\nNow let's take a closer look at the medication card for diphenhydramine and cetirizine in Table 5.6.[footnote]This work is a derivative of <a href=\"https:\/\/www.oercommons.org\/authoring\/54330-pharmacology-notes-nursing-implications-for-clinic\/view\" rel=\"noopener noreferrer\">Pharmacology Notes: Nursing Implications for Clinical Practice<\/a> by <a href=\"https:\/\/www.oercommons.org\/profile\/213497\" rel=\"noopener noreferrer\">Gloria Velarde<\/a> licensed under <a class=\"internal\" href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/\" rel=\"noopener noreferrer\">CC BY-NC-SA 4.0<\/a>.[\/footnote], [footnote]Frandsen, G. &amp; Pennington, S. (2018). <em>Abrams\u2019 clinical drug: Rationales for nursing practice <\/em>(11th ed.). Wolters Kluwer.[\/footnote], [footnote]This work is a derivative of <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" rel=\"noopener noreferrer\">Daily Med<\/a> by <a href=\"https:\/\/www.nlm.nih.gov\/\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a> in the <a class=\"internal\" href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" rel=\"noopener noreferrer\">public domain<\/a>. [\/footnote] Medication cards are intended to assist students to learn key points about each medication class.\u00a0 Basic information related to a common generic medication in this class is outlined, including administration considerations, therapeutic effects, and side effects\/adverse effects.\u00a0 Prototype\/generic medication listed in the medication card is also hyperlinked to a free resource from\u00a0 <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/index.cfm\" rel=\"noopener noreferrer\">Daily Med<\/a>.\u00a0 Because information about medication is constantly changing, nurses should always consult evidence-based resources to review current recommendations before administering specific medication.\r\n<div class=\"textbox textbox--learning-objectives\"><header class=\"textbox__header\">\r\n<h2 class=\"textbox__title\">Medication Card 5.6.1: Diphenhydramine<\/h2>\r\n<\/header>\r\n<div class=\"textbox__content\">\r\n\r\n<strong>Class: <\/strong>Antihistamines (first generation)\r\n\r\n<strong>Prototypes: <\/strong>Diphenhydramine (Benadryl)\r\n\r\n<strong>Mechanism: <\/strong>Blocks histamine at H1 receptor, inhibits smooth muscle constriction in blood vessels and respiratory and GI tracts: decreases capillary permeability, salivation and tear formation\r\n<h3>Therapeutic Effects<\/h3>\r\n<ul>\r\n \t<li>Relieves allergic reactions and temporarily relieves\u00a0symptoms due to hay fever or other upper respiratory allergies: runny nose; sneezing; itchy, watery eyes; itching of the nose or throat. For example: Common cold symptom management<\/li>\r\n<\/ul>\r\n<h3>Administration<\/h3>\r\n<ul>\r\n \t<li>PO\/IV\/IM\/Suppository<\/li>\r\n \t<li>Common dosages for adult PO 25-50mg q4-6hrs PRN. IV 10-50mg IM or IV<\/li>\r\n \t<li>Common dosages for children 4 years and older 1.25mg per kg or body weight injected IM (intramuscularly) up to 4 times per day<\/li>\r\n<\/ul>\r\n<h3>Indications<\/h3>\r\n<ul>\r\n \t<li>Common Cold<\/li>\r\n \t<li>Respiratory Allergies<\/li>\r\n \t<li>Mild allergic reactions<\/li>\r\n<\/ul>\r\n<h3>Contraindications<\/h3>\r\n<ul>\r\n \t<li>Avoid alcohol and CNS depressants due to risk of sedation<\/li>\r\n<\/ul>\r\n<h3>Side Effects<\/h3>\r\n<ul>\r\n \t<li>Sedation Anticholinergic effects Gastrointestinal: Nausea\/Vomiting<\/li>\r\n \t<li>Paradoxical effect: excitation in children<\/li>\r\n \t<li><strong>S<\/strong><strong>AFETY<\/strong><strong>:<\/strong> Note the name is close to Dimenhydramine (gravol) so double check you have the right medication<\/li>\r\n<\/ul>\r\n<h3>Nursing Considerations<\/h3>\r\n<ul>\r\n \t<li>Administer as per policies. Sedation is a very serious consideration especially with intravenous administration.<\/li>\r\n \t<li>Monitor respirations ensure resps are over 12 resps per minute<\/li>\r\n \t<li>Consider second and third generation antihistamines since they have less sedative properties<\/li>\r\n<\/ul>\r\n<\/div>\r\n<\/div>","rendered":"<h1>Antihistamines<\/h1>\n<p>Diphenhydramine and Cetirizine are two commonly-seen antihistamine drugs. In this chapter we explore Diphenhydramine.<\/p>\n<p>Diphenhydramine is an example of a first-generation antihistamine. (See Figures 5.6a<a class=\"footnote\" title=\"&quot;Benadryl Allergy USA&quot; by ZenBenjamin is licensed under CC BY-NC-SA 2.0\" id=\"return-footnote-230-1\" href=\"#footnote-230-1\" aria-label=\"Footnote 1\"><sup class=\"footnote\">[1]<\/sup><\/a> and 5.6b.<a class=\"footnote\" title=\"&quot;diphenhydramine (1)&quot; by Intropin is licensed under CC BY-NC 2.0\" id=\"return-footnote-230-2\" href=\"#footnote-230-2\" aria-label=\"Footnote 2\"><sup class=\"footnote\">[2]<\/sup><\/a><\/a>)\u00a0 Second-generation antihistamines were developed to have fewer side effects. An example of a second-generation antihistamine is cetirizine.<\/p>\n<figure id=\"attachment_227\" aria-describedby=\"caption-attachment-227\" style=\"width: 339px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-227\" title=\"&quot;Benadryl Allergy USA&quot; by ZenBenjamin is licensed under CC BY-NC-SA 2.0\" src=\"https:\/\/opentextbc.ca\/accessibilitytoolkit\/wp-content\/uploads\/sites\/397\/2019\/11\/image11-5.png\" alt=\"An opened package of Benadryl.\" width=\"339\" height=\"254\" srcset=\"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/11\/image11-5.png 1024w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/11\/image11-5-300x225.png 300w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/11\/image11-5-768x576.png 768w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/11\/image11-5-65x49.png 65w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/11\/image11-5-225x169.png 225w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2019\/11\/image11-5-350x263.png 350w\" sizes=\"auto, (max-width: 339px) 100vw, 339px\" \/><figcaption id=\"caption-attachment-227\" class=\"wp-caption-text\">Figure 5.6a Diphenhydramine is a first-generation antihistamine that is available orally or as an IV medication<\/figcaption><\/figure>\n<figure id=\"attachment_228\" aria-describedby=\"caption-attachment-228\" style=\"width: 259px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-228\" title=\"&quot;diphenhydramine (1)&quot; by M is licensed under CC BY-NC 2.0\" src=\"https:\/\/opentextbc.ca\/accessibilitytoolkit\/wp-content\/uploads\/sites\/397\/2022\/05\/image10-4-225x300.png\" alt=\"A bottle of diphenhydramine HCI.\" width=\"259\" height=\"345\" srcset=\"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2022\/05\/image10-4-225x300.png 225w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2022\/05\/image10-4-65x87.png 65w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2022\/05\/image10-4-350x467.png 350w, https:\/\/opentextbc.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/397\/2022\/05\/image10-4.png 768w\" sizes=\"auto, (max-width: 259px) 100vw, 259px\" \/><figcaption id=\"caption-attachment-228\" class=\"wp-caption-text\">Figure 5.6b Diphenhydramine HCl preparation, single dose vial for IV administration<\/figcaption><\/figure>\n<h2>Mechanism of Action<\/h2>\n<p>Antihistamines have the following mechanisms of action: blocks histamine at H1 receptors; inhibits smooth muscle constriction in blood vessels and the respiratory and GI tracts; and decreases capillary permeability, salivation, and tear formation.<\/p>\n<h2>Indications for Use<\/h2>\n<p>Antihistamines are used for relief of allergy or cold symptoms.<\/p>\n<h2>Nursing Considerations Across the Lifespan<\/h2>\n<p>This medication is not safe for children under the age of 2 years without a healthcare provider&#8217;s order.<\/p>\n<h2>Adverse\/Side Effects<\/h2>\n<p>First-generation medications can cause anticholinergic effects (such as dry mouth, urinary retention, constipation and blurred vision). CNS depression or CNS stimulation with excessive doses can occur, especially in children. Therefore, first-generation antihistamines should be used with caution in the elderly.<\/p>\n<p>Second-generation medications may cause headache, nausea, vomiting, dysmenorrhea, and fatigue.<a class=\"footnote\" title=\"Frandsen, G. &amp; Pennington, S. (2018). Abrams\u2019 clinical drug: Rationales for nursing practice (11th ed.). Wolters Kluwer.\" id=\"return-footnote-230-3\" href=\"#footnote-230-3\" aria-label=\"Footnote 3\"><sup class=\"footnote\">[3]<\/sup><\/a><\/p>\n<h2>Client Teaching &amp; Education<\/h2>\n<p>Clients should be advised that antihistamines may cause drowsiness, and concurrent use of alcohol or other CNS depressants should be avoided.\u00a0 Clients should take only the recommended amount of medication and not exceed dosing recommendations.\u00a0 Some clients may experience side effects such as dry mouth, and frequent oral hygiene may assist in alleviating discomfort.<a class=\"footnote\" title=\"uCentral from Unbound Medicine. https:\/\/www.unboundmedicine.com\/ucentral\" id=\"return-footnote-230-4\" href=\"#footnote-230-4\" aria-label=\"Footnote 4\"><sup class=\"footnote\">[4]<\/sup><\/a><\/p>\n<h1>Diphenhydramine Medication Card<\/h1>\n<p>Now let&#8217;s take a closer look at the medication card for diphenhydramine and cetirizine in Table 5.6.<a class=\"footnote\" title=\"This work is a derivative of Pharmacology Notes: Nursing Implications for Clinical Practice by Gloria Velarde licensed under CC BY-NC-SA 4.0.\" id=\"return-footnote-230-5\" href=\"#footnote-230-5\" aria-label=\"Footnote 5\"><sup class=\"footnote\">[5]<\/sup><\/a>, <a class=\"footnote\" title=\"Frandsen, G. &amp; Pennington, S. (2018). Abrams\u2019 clinical drug: Rationales for nursing practice (11th ed.). Wolters Kluwer.\" id=\"return-footnote-230-6\" href=\"#footnote-230-6\" aria-label=\"Footnote 6\"><sup class=\"footnote\">[6]<\/sup><\/a>, <a class=\"footnote\" title=\"This work is a derivative of Daily Med by U.S. National Library of Medicine in the public domain.\" id=\"return-footnote-230-7\" href=\"#footnote-230-7\" aria-label=\"Footnote 7\"><sup class=\"footnote\">[7]<\/sup><\/a> Medication cards are intended to assist students to learn key points about each medication class.\u00a0 Basic information related to a common generic medication in this class is outlined, including administration considerations, therapeutic effects, and side effects\/adverse effects.\u00a0 Prototype\/generic medication listed in the medication card is also hyperlinked to a free resource from\u00a0 <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/index.cfm\" rel=\"noopener noreferrer\">Daily Med<\/a>.\u00a0 Because information about medication is constantly changing, nurses should always consult evidence-based resources to review current recommendations before administering specific medication.<\/p>\n<div class=\"textbox textbox--learning-objectives\">\n<header class=\"textbox__header\">\n<h2 class=\"textbox__title\">Medication Card 5.6.1: Diphenhydramine<\/h2>\n<\/header>\n<div class=\"textbox__content\">\n<p><strong>Class: <\/strong>Antihistamines (first generation)<\/p>\n<p><strong>Prototypes: <\/strong>Diphenhydramine (Benadryl)<\/p>\n<p><strong>Mechanism: <\/strong>Blocks histamine at H1 receptor, inhibits smooth muscle constriction in blood vessels and respiratory and GI tracts: decreases capillary permeability, salivation and tear formation<\/p>\n<h3>Therapeutic Effects<\/h3>\n<ul>\n<li>Relieves allergic reactions and temporarily relieves\u00a0symptoms due to hay fever or other upper respiratory allergies: runny nose; sneezing; itchy, watery eyes; itching of the nose or throat. For example: Common cold symptom management<\/li>\n<\/ul>\n<h3>Administration<\/h3>\n<ul>\n<li>PO\/IV\/IM\/Suppository<\/li>\n<li>Common dosages for adult PO 25-50mg q4-6hrs PRN. IV 10-50mg IM or IV<\/li>\n<li>Common dosages for children 4 years and older 1.25mg per kg or body weight injected IM (intramuscularly) up to 4 times per day<\/li>\n<\/ul>\n<h3>Indications<\/h3>\n<ul>\n<li>Common Cold<\/li>\n<li>Respiratory Allergies<\/li>\n<li>Mild allergic reactions<\/li>\n<\/ul>\n<h3>Contraindications<\/h3>\n<ul>\n<li>Avoid alcohol and CNS depressants due to risk of sedation<\/li>\n<\/ul>\n<h3>Side Effects<\/h3>\n<ul>\n<li>Sedation Anticholinergic effects Gastrointestinal: Nausea\/Vomiting<\/li>\n<li>Paradoxical effect: excitation in children<\/li>\n<li><strong>S<\/strong><strong>AFETY<\/strong><strong>:<\/strong> Note the name is close to Dimenhydramine (gravol) so double check you have the right medication<\/li>\n<\/ul>\n<h3>Nursing Considerations<\/h3>\n<ul>\n<li>Administer as per policies. Sedation is a very serious consideration especially with intravenous administration.<\/li>\n<li>Monitor respirations ensure resps are over 12 resps per minute<\/li>\n<li>Consider second and third generation antihistamines since they have less sedative properties<\/li>\n<\/ul>\n<\/div>\n<\/div>\n<hr class=\"before-footnotes clear\" \/><div class=\"footnotes\"><ol><li id=\"footnote-230-1\">\"<a href=\"https:\/\/www.flickr.com\/photos\/zenbenjamin\/4948476952\" rel=\"noopener noreferrer\">Benadryl Allergy USA<\/a>\" by <a href=\"https:\/\/www.flickr.com\/photos\/zenbenjamin\/\" rel=\"noopener noreferrer\">ZenBenjamin<\/a> is licensed under <a class=\"internal\" href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/2.0\/\" rel=\"noopener noreferrer\">CC BY-NC-SA 2.0<\/a> <a href=\"#return-footnote-230-1\" class=\"return-footnote\" aria-label=\"Return to footnote 1\">&crarr;<\/a><\/li><li id=\"footnote-230-2\">\"<a href=\"https:\/\/commons.wikimedia.org\/wiki\/File:Diphenhydramine_(1).JPG\" rel=\"noopener noreferrer\">diphenhydramine (1)<\/a>\" by <a href=\"https:\/\/commons.wikimedia.org\/wiki\/User:Intropin\" rel=\"noopener noreferrer\">Intropin<\/a> is licensed under<a class=\"internal\" href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/2.0\/\" rel=\"noopener noreferrer\"> CC BY-NC 2.0 <a href=\"#return-footnote-230-2\" class=\"return-footnote\" aria-label=\"Return to footnote 2\">&crarr;<\/a><\/li><li id=\"footnote-230-3\">Frandsen, G. &amp; Pennington, S. (2018). <em>Abrams\u2019 clinical drug: Rationales for nursing practice <\/em>(11th ed.). Wolters Kluwer. <a href=\"#return-footnote-230-3\" class=\"return-footnote\" aria-label=\"Return to footnote 3\">&crarr;<\/a><\/li><li id=\"footnote-230-4\">uCentral from Unbound Medicine. <a href=\"https:\/\/www.unboundmedicine.com\/ucentral\" rel=\"noopener noreferrer\">https:\/\/www.unboundmedicine.com\/ucentral<\/a> <a href=\"#return-footnote-230-4\" class=\"return-footnote\" aria-label=\"Return to footnote 4\">&crarr;<\/a><\/li><li id=\"footnote-230-5\">This work is a derivative of <a href=\"https:\/\/www.oercommons.org\/authoring\/54330-pharmacology-notes-nursing-implications-for-clinic\/view\" rel=\"noopener noreferrer\">Pharmacology Notes: Nursing Implications for Clinical Practice<\/a> by <a href=\"https:\/\/www.oercommons.org\/profile\/213497\" rel=\"noopener noreferrer\">Gloria Velarde<\/a> licensed under <a class=\"internal\" href=\"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/\" rel=\"noopener noreferrer\">CC BY-NC-SA 4.0<\/a>. <a href=\"#return-footnote-230-5\" class=\"return-footnote\" aria-label=\"Return to footnote 5\">&crarr;<\/a><\/li><li id=\"footnote-230-6\">Frandsen, G. &amp; Pennington, S. (2018). <em>Abrams\u2019 clinical drug: Rationales for nursing practice <\/em>(11th ed.). Wolters Kluwer. <a href=\"#return-footnote-230-6\" class=\"return-footnote\" aria-label=\"Return to footnote 6\">&crarr;<\/a><\/li><li id=\"footnote-230-7\">This work is a derivative of <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" rel=\"noopener noreferrer\">Daily Med<\/a> by <a href=\"https:\/\/www.nlm.nih.gov\/\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a> in the <a class=\"internal\" href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" rel=\"noopener noreferrer\">public domain<\/a>.  <a href=\"#return-footnote-230-7\" class=\"return-footnote\" aria-label=\"Return to footnote 7\">&crarr;<\/a><\/li><\/ol><\/div>","protected":false},"author":90,"menu_order":6,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":[],"pb_section_license":""},"chapter-type":[50],"contributor":[],"license":[],"class_list":["post-230","chapter","type-chapter","status-publish","hentry","chapter-type-numberless"],"part":209,"_links":{"self":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/users\/90"}],"version-history":[{"count":7,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/230\/revisions"}],"predecessor-version":[{"id":1730,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/230\/revisions\/1730"}],"part":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/209"}],"metadata":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/230\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/media?parent=230"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=230"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/contributor?post=230"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/opentextbc.ca\/nursingpharmacology\/wp-json\/wp\/v2\/license?post=230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}